Healthcare & wellbeing
Digital companion for patients with a chronic disease.
Elsa
Company info
Company mission

The problem

According to the World Health Organisation, roughly half of all cancer deaths are due to late-stage diagnoses, highlighting the need for more effective early detection methods to best improve patient outcomes.

The solution

Elypta is a developing a new method for early cancer detection. Their approach involves analysing a substance called the GAGome in a urine or plasma sample and using machine learning to identify patterns that might indicate cancer.

Company achievements

210

Patients with rheumatic disease enrolled in a randomised control trial to improve wellbeing.

01

/

01

02

03

02

/

02

03

03

/

03

No related articles published